halopemide has been researched along with 5-fluoro-2-indolyldeschlorohalopemide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyar, W; Du, Z; LaSala, D; LaVoie, S; Liu, E; Monovich, L; Mugrage, B; Quadros, E; Steed, P; Tommasi, R; Toscano, K | 1 |
| Armstrong, MD; Arteaga, CL; Brown, HA; Buck, JR; Cho, HP; Criswell, TL; Lindsley, CW; Scott, SA; Selvy, PE; Thomas, AL | 1 |
2 other study(ies) available for halopemide and 5-fluoro-2-indolyldeschlorohalopemide
| Article | Year |
|---|---|
Optimization of halopemide for phospholipase D2 inhibition.
Topics: Administration, Oral; Amides; Animals; Anti-Inflammatory Agents; Domperidone; Enzyme Inhibitors; Inhibitory Concentration 50; Pharmacokinetics; Phospholipase D; Rats; Structure-Activity Relationship | 2007 |
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Topics: Breast Neoplasms; Drug Design; Enzyme Inhibitors; Humans; Isoenzymes; Neoplasm Invasiveness; Phospholipase D | 2009 |